A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Clinical trial NCT07767903 · RECRUITING
Trial details
- NCT number
- NCT07767903
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-07
- Primary completion
- 2028-10-25
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.